Intuitive Surgical reported Q1 fiscal 2026 revenue of $2.77 billion, up 23% year-over-year and beating expectations by 5.5%. Earnings per share rose 38% to $2.50, surpassing forecasts by nearly 17%, driven by higher procedure volumes and system placements. The company installed 431 new systems, including strong demand for the next-gen da Vinci 5 surgical system. Management raised its full-year procedure growth outlook to 13.5%-15.5%, citing healthy utilization and international growth despite challenges in China and Japan. Operating expense growth guidance was lowered, supporting margins amid macroeconomic uncertainties.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
